CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.

CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 325 plasma collection centers in the USA, Europe and China. The plasma collected is used by CSL Behring for the purpose of manufacturing and delivering its life-saving therapies to people in more than 100 countries.

As the only vaccine company with a singular global focus on influenza, we work tirelessly on cutting-edge research, transformative technologies, and the latest methods of production and distribution.

The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.